Diamond Hill Capital, an investment management company, released its “Large Cap Fund” third-quarter 2025 investor letter. A ...

Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...

Thermo Fisher Scientific shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...

From smartphones to autonomous cars to AI supercomputers, nearly every electronic innovation we use today depends on ...

Thermo Fisher Scientific (NYSE:TMO) just announced a big win for shareholders a $5 billion stock buyback plan with no expiration date. That means the company can repurchase shares at its own pace, ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.

On October 27, Thermo Fisher Scientific and Lundbeck both announced new collaborations with OpenAI. These moves represent a continuing trend of drug development companies inking deals with technology ...

The initiative reflects the PPD business’ vision to promote sustainability throughout the clinical development ecosystem.

Thermo Fisher Scientific invests ₹160 crore to expand its Bengaluru R&D centre, enhancing research in infectious diseases and ...

Thermo Fisher Scientific is set to acquire Clario Holdings after entering a $8.8 billion definitive agreement, which includes ...

Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for ...

Thermo Fisher's stock offers attractive upside, backed by pharma recovery, margin expansion, and AI-driven efficiency. Read ...